Restylane: Difference between revisions
No edit summary |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
''' | '''Editors-In-Chief:''' Martin I. Newman, M.D., FACS, Cleveland Clinic Florida, [mailto:Newmanm@ccf.org]; [[User:Mcs|Michel C. Samson, M.D., FRCSC, FACS]] [mailto:samsonm1@ccf.org] | ||
==Overview== | ==Overview== | ||
'''Restylane''' is the trade name for a specific formulation of non-animal sourced [[hyaluronic acid]] most commonly used for lip augmentation. In the United States, Restylane has been approved by the [[FDA]] for cosmetic injection into subdermal facial tissues.<ref>[http://www.fda.gov/cdrh/MDA/DOCS/p020023.html FDA approval]</ref> | '''Restylane''' is the trade name for a specific formulation of non-animal sourced [[hyaluronic acid]] most commonly used for lip augmentation. In the United States, Restylane has been approved by the [[FDA]] for cosmetic injection into subdermal facial tissues.<ref>[http://www.fda.gov/cdrh/MDA/DOCS/p020023.html FDA approval]</ref> | ||
| Line 33: | Line 33: | ||
{{Plastic surgery}} | {{Plastic surgery}} | ||
{{Cleft lip and palate}} | {{Cleft lip and palate}} | ||
[[Category:Glycosaminoglycans]] | [[Category:Glycosaminoglycans]] | ||
Latest revision as of 15:40, 20 August 2012
|
WikiDoc Resources for Restylane |
|
Articles |
|---|
|
Most recent articles on Restylane |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Restylane at Clinical Trials.gov Clinical Trials on Restylane at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Restylane
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Restylane Discussion groups on Restylane Directions to Hospitals Treating Restylane Risk calculators and risk factors for Restylane
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Restylane |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editors-In-Chief: Martin I. Newman, M.D., FACS, Cleveland Clinic Florida, [1]; Michel C. Samson, M.D., FRCSC, FACS [2]
Overview
Restylane is the trade name for a specific formulation of non-animal sourced hyaluronic acid most commonly used for lip augmentation. In the United States, Restylane has been approved by the FDA for cosmetic injection into subdermal facial tissues.[1]
Restylane is injected under wrinkles and aging lines of the face such as the nasolabial folds, melomental folds, "crows feet" and forehead wrinkles. It may also be used for filling aging-related facial hollows and "orbital troughs" (under and around the eyes). The process has a fast recovery time of 2 to 3 days. However, it is not permanent; reapplication is recommended every six months or so. Costs can be anywhere between $300 and $500 per treatment. [2]
The effects of Restylane last around six months. Recovery time from an injection takes around three days, as swelling and bruising can be a problem. Some practitioners will ask their patients to return to the practice two or three weeks after treatment for reassessment with view to a "top-up" if required.
A new way to use Restylane was described in the August 2007 issue of the Journal of Drugs in Dermatology by Dutch cosmetic doctor Tom van Eijk, whose "fern pattern" injection technique aims to restore dermal elasticity rather than to fill underneath the wrinkles. [3]
References
- ↑ FDA approval
- ↑ Restylane Details
- ↑ Van Eijk, Tom; Braun, M. (2007). "A Novel Method to Inject Hyaluronic Acid: The Fern Pattern Technique". Journal of Drugs in Dermatology. 6 (8): 805–8. Retrieved 2008-06-27.
External links
|
Cleft lip and palate Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Restylane On the Web |
|
American Roentgen Ray Society Images of Restylane |